May Hill Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.11M Buy
1,758
+269
+18% +$275K 0.44% 50
2026
Q1
$1.37M Sell
1,489
-96
-6% -$97.3K 0.34% 56
2025
Q4
$1.7M Buy
1,585
+216
+16% +$207K 0.46% 44
2025
Q3
$1.04M Buy
1,369
+108
+9% +$80.4K 0.31% 55
2025
Q2
$983K Sell
1,261
-321
-20% -$249K 0.32% 56
2025
Q1
$1.31M Buy
1,582
+21
+1% +$17.5K 0.49% 37
2024
Q4
$1.21M Buy
+1,561
New +$1.29M 0.47% 40

Other funds holding LLY

May Hill Capital's LLY Position: Q2 2026 in Review

May Hill Capital increased its Eli Lilly (LLY) stake by 18% in Q2 2026, buying an estimated $275K and bringing the position to 1,758 shares worth $2.11M. The position accounts for 0.44% of the portfolio, ranked #50.

May Hill Capital first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • May Hill Capital held 1,758 shares of Eli Lilly worth $2.11M as of Q2 2026.
  • May Hill Capital bought 269 Eli Lilly shares in Q2 2026, an estimated $275K.
  • Eli Lilly made up 0.44% of May Hill Capital's portfolio in Q2 2026, its #50 holding.
  • May Hill Capital first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on May Hill Capital's 13F filing for Q2 2026, filed 7 Aug 2026.